Treatment characteristics
| No. of stents deployed | |||
| 0 | 6 | ||
| 1 | 136 | ||
| 2 | 10 | ||
| Stent modalities | |||
| Balloon-mounted, bare metal | 78 | ||
| Balloon-mounted, drug-eluting | 21 | ||
| Self-expanding | 47 | ||
| Total | 146 | ||
| Anesthesia technique | |||
| MAC | 36 | ||
| GETA | 106 | ||
| Stent types | |||
| AVE Series | 53 | ||
| Bx Velocity | 11 | ||
| Driver | 15 | ||
| Palmaz | 2 | ||
| Wingspan | 37 | ||
| Othera | 28 | ||
| Total | 146 | ||
| Stent-designed indications | |||
| Coronary | 95 | ||
| Neuro | 40 | ||
| Peripheral | 11 | ||
| Total | 146 | ||
| Angiographic results | |||
| Mori | Pretreatment stenosis | Posttreatment stenosis | Success |
| A (n = 19) | 80.8% | 3.9% | 84.2% |
| B (n = 73) | 80.2% | 7.8% | 89.0% |
| C (n = 50) | 86.0% | 13.8% | 86.0% |
Note:—MAC indicates monitors anesthesia care; GETA, general endotracheal anesthesia.
↵a Cypher, Enterprise, Herculink, Multi-Link, Neuroform, NIR Primo, Precise, Sprint, Taxus.